Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |